Follow us...

 

Search News Archives

News Channels

 

New Laboratory Products

Lab News

What's going on at Lab Innovations

Research & Case Studies

Microscopy | Image Analysis

Separation Science

Brochures & Literature

Videos

Events | Webinars

 

 

Conferences | Events

CEM Launches the Liberty PRIME Peptide Synthesizer

publication date: Apr 18, 2018
 | 
author/source: CEM Corporation
20180412_1

CEM Corporation is proud to announce the release of the new Liberty PRIME™ automated microwave peptide synthesizer.

The Liberty PRIME is the most efficient peptide synthesizer ever made and utilizes a new methodology for solid phase peptide synthesis. It features an unprecedented 2 min complete cycle time (at 0.1 mmol scale) and produces only 50% of the waste per cycle compared to CEM’s highly efficient Liberty Blue™ peptide synthesizer. The Liberty PRIME automatically synthesizes up to 24 peptides and is ideal for high-throughput synthesis of standard and complex peptides.

The improved efficiency of the Liberty PRIME is based on the development of a “one-pot” coupling and deprotection SPPS process whereby the deprotection step is initiated directly in the coupling solution without draining.1 This process results in significant time and solvent savings and is achieved with a new integrated non-pressurized pumping system for extremely accurate and fast reagent delivery.

The purity of peptides made on the Liberty PRIME are at the highest level based on the use of CEM’s new patented CarboMAX™ coupling methodology at elevated temperature.2 CarboMAX improves standard carbodiimide chemistry by providing faster activation, less epimerization, and increased stabilization of acid-sensitive linkages (ex. phospho, glyco, hyper-acid sensitive resin linkages). The standard methods used on the Liberty PRIME also allows minimal epimerization of all 20 standard amino acids at 100°C even including histidine and cysteine. This allows the use of a standard method without the need for routine sequence based optimization.“The Liberty PRIME represents a major advancement in SPPS methodology and engineering over anything we’ve ever done. We are excited to see this technology be used in the market and provide benefit to the growing need for synthetic peptides” says Jonathan M. Collins, Vice President of Business Development.

(1) Patent Pending: US20170226152; WO2017070512 | (2) Patent Pending: US20160176918, EP3037430, JP2016138090, CN105713066, AU2017204172


more news from CEM


About CEM

CEM Corporation, a private company based in Matthews, North Carolina, is a leading provider of laboratory instrumentation. The Company has subsidiaries in the United Kingdom, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for life sciences, analytical laboratories and processing plants worldwide. The Company’s products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.



If you have not logged into the website then please enter your details below.



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


Promotions

 

Media Partners